|

Methylprednisolone Clinical Trials

17 actively recruiting trials across 11 locations

Also known as: Adlone, Caberdelta M, DepMedalone, Depo Moderin, Depo-Medrol, Solu-Medrol, Methyl Prednisolonate, Depo-Nisolone, Duralone, Emmetipi, Esametone, Firmacort, Medlone 21, Medrate, Medrol, Medrol Veriderm, Medrone, Mega-Star, Meprolone, Methylprednisolonum, Metilbetasone Solubile, Metrocort, Metypresol, Metysolon, Predni-M-Tablinen, Prednilen, Radilem, Sieropresol, Solpredone, Solu-Medrol, Summicort, Urbason, Veriderm Medrol, Wyacort

Other4 trials

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
Phase 3
Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery
Phase 4
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
Phase 2
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
N/A

West Hollywood, California2 trials

A Trial of Selinexor, Ruxolitinib and Methylprednisolone

Berenson Cancer Center

Phase 1
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Berenson Cancer Center

Early 1

Houston, Texas2 trials

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

M D Anderson Cancer Center

N/A
Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M D Anderson Cancer Center

Phase 2

Birmingham, Alabama1 trial

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Children's Hospital of Alabama

Phase 2

Scottsdale, Arizona1 trial

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)

Mayo Clinic, 13400 E. Shea Boulevard

Phase 1/2

Alhambra, California1 trial

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Global Oncology, Inc.

Phase 1

Loma Linda, California1 trial

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Loma Linda University health

Phase 2

Los Angeles, California1 trial

TReatment for ImmUne Mediated PathopHysiology

Children's Hospital Los Angeles

Phase 2

San Diego, California1 trial

MYTHS - MYocarditis THerapy With Steroids

University of California San Diego

Phase 3

Atlanta, Georgia1 trial

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Emory University Hospital/Winship Cancer Institute

Phase 4

Bethesda, Maryland1 trial

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

National Institutes of Health Clinical Center

Phase 2

New York, New York1 trial

Oral Steroid Taper After Total Knee Arthroplasty

Columbia University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.